The market was valued at $18.5 billion in 2011 and reached $19 billion in 2012.
The report also estimates 30 percent of all healthcare products currently under develop are combination devices with built-in pharmaceutical or biologic components.
Combination devices include orthopedic applications, coronary stents, photodynamic therapies and antimicrobial catheters.
More Articles on Devices:
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
Orthopedic Device Company DJO Global Acquires Exos Corp
